
SBI HEALTHCARE OPPORTUNITIES FUND - Direct Plan - Growth
SBI Mutual Fund · Sectoral/Thematic · Direct · Growth
NAV · as of 11/09/2026
605.91
1D
-0.28%1Y
-Key stats
- Expense ratio
- 1.02%
- AUM
- ₹5.80 K Cr
- Launched
- 01/01/2013
- Fund manager
- Tanmaya Desai
- Portfolio turnover
- 0.35%
- Risk
- Very High Risk
- Min lump-sum
- ₹5,000
- Min SIP
- ₹500/mo
- Fresh lump-sum
- Accepted
- Fresh SIP
- Accepted
NAV history
SBI HEALTHCARE OPPORTUNITIES FUND - Direct Plan - Growth
13/08/2026 to 11/09/2026
O - H - L -
Top holdings
36 disclosed- 1.11.18%
Sun Pharmaceuticals Industries Ltd
Healthcare
- 2.6.35%
Acutaas Chemicals Ltd
Basic Materials
- 3.5.92%
Divi's Laboratories Ltd
Healthcare
- 4.5.21%
Apollo Hospitals Enterprise Ltd
Healthcare
- 5.5.08%
Max Healthcare Institute Ltd Ordinary Shares
Healthcare
- 6.4.17%
Aurobindo Pharma Ltd
Healthcare
- 7.3.77%
Aster DM Healthcare Ltd Ordinary Shares
Healthcare
- 8.3.64%
Laurus Labs Ltd
Healthcare
- 9.3.52%
Cipla Ltd
Healthcare
- 10.3.33%
Torrent Pharmaceuticals Ltd
Healthcare
- 11.3.14%
Biocon Ltd
Healthcare
- 12.3.03%
Treps
- 13.3.00%
Gland Pharma Ltd
Healthcare
- 14.2.87%
Fortis Healthcare Ltd
Healthcare
- 15.2.85%
Mankind Pharma Ltd
Healthcare
- 16.2.84%
Anthem Biosciences Ltd
Healthcare
- 17.2.72%
Aether Industries Ltd
Basic Materials
- 18.2.56%
Jupiter Life Line Hospitals Ltd
Healthcare
- 19.2.47%
Sai Life Sciences Ltd
Healthcare
- 20.2.31%
Sudeep Pharma Ltd
Healthcare
- 21.2.17%
Krishna Institute of Medical Sciences Ltd
Healthcare
- 22.2.16%
Poly Medicure Ltd
Healthcare
- 23.2.05%
Ajanta Pharma Ltd
Healthcare
- 24.2.04%
Lonza Group Ltd ADR
Healthcare
- 25.2.01%
Cohance Lifesciences Ltd
Healthcare
- 26.1.94%
Lupin Ltd
Healthcare
- 27.1.84%
Concord Biotech Ltd
Healthcare
- 28.1.47%
Global Health Ltd
Healthcare
- 29.1.22%
Abbott India Ltd
Healthcare
- 30.1.08%
Nephrocare Health Services Ltd
Healthcare
- 31.0.99%
Dr. Lal PathLabs Ltd
Healthcare
- 32.0.85%
Rainbow Childrens Medicare Ltd
Healthcare
- 33.0.41%
Gufic Biosciences Ltd
Healthcare
- 34.0.26%
Net Receivable / Payable
- 35.0.06%
Day Tbill
- 36.-
Alkem Laboratories Ltd
Sector allocation
- Healthcare88.10%
- Basic Materials9.07%
- Unclassified3.36%
Comparable peers
SBI Healthcare Opportunities Growth Direct Plan
SBI Healthcare Opportunities (G) · ₹5.80 K Cr AUM
1Y+22.13%3Y+24.61%-Mirae Asset Healthcare Growth Direct Plan
Mirae Healthcare (G) · ₹3.44 K Cr AUM
1Y+20.35%3Y+23.20%-LIC Healthcare Growth Direct Plan
LIC Healthcare (G) · ₹97.60 Cr AUM
1Y+17.81%3Y+23.11%-UTI Healthcare Growth Direct Plan
UTI Healthcare (G) · ₹1.44 K Cr AUM
1Y+17.28%3Y+24.42%-HDFC Transportation & Logistics Growth Direct Plan
HDFC Transportation & Logistics (G) · ₹1.96 K Cr AUM
1Y+9.79%3Y+25.46%-
Investment objective
To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Scheme details
- Scheme code
- 119783
- Fund house
- SBI Mutual Fund
- Category
- Open Ended
- Type
- Equity Scheme
- Sub-category
- Sectoral/Thematic
- Plan
- Direct
- Return type
- Growth
- ISIN (Growth)
- INF200K01UP2
- ISIN (Div. Reinvest)
- -
- Tradable on exchange
- No